Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunoreactive parvalbumin concentrations in parahippocampal gyrus decrease in patients with Alzheimer's disease.

Y Inaguma1, H Shinohara, T Inagaki

  • 1Department of Biochemistry, Aichi Prefectural Colony, Japan.

Journal of the Neurological Sciences
|July 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Laparoscopic and open surgery in patients with transverse colon cancer: short-term and oncological outcomes.

BJS open·2021
Same author

A novel surgical strategy for the resection of duodenal gastrointestinal stromal tumours located close to the duodenal ampulla: a case report.

Annals of the Royal College of Surgeons of England·2019
Same author

Blister-based-laser-induced-forward-transfer: a non-contact, dry laser-based transfer method for nanomaterials.

Nanotechnology·2018
Same author

Correction: Band gap modification and photoluminescence enhancement of graphene nanoribbon filled single-walled carbon nanotubes.

Nanoscale·2018
Same author

Band gap modification and photoluminescence enhancement of graphene nanoribbon filled single-walled carbon nanotubes.

Nanoscale·2018
Same author

Inferior pancreatic approach for laparoscopic splenic flexure mobilization.

Techniques in coloproctology·2017
Same journal

Distinguishing drug-target effects from natural lipid variation and incorporating imaging outcomes in Mendelian randomisation studies of multiple sclerosis.

Journal of the neurological sciences·2026
Same journal

Long-term social cognitive impairment after ischemic stroke: Frequency and association with lesion volume and location in an exploratory pilot study.

Journal of the neurological sciences·2026
Same journal

Subjective cognitive decline among U.S. Cancer survivors, 2017-2024: Prevalence, cancer-specific patterns, and associated factors.

Journal of the neurological sciences·2026
Same journal

Comment on "Comparative impact of mental and cardiovascular comorbidities on adverse outcomes in people with MS".

Journal of the neurological sciences·2026
Same journal

Comment on "Efficacy and safety of conventional immunosuppressant therapies in elderly patients with Neuromyelitis optica spectrum disorder: A target trial emulation study".

Journal of the neurological sciences·2026
Same journal

Increasing incidence of varicella-zoster virus meningitis in Japan, 2011-2022.

Journal of the neurological sciences·2026
See all related articles

Alzheimer's disease significantly reduces parvalbumin levels in the hippocampus. This study measured parvalbumin in four brain regions, finding lower concentrations specifically in the parahippocampal gyrus of Alzheimer's patients.

Area of Science:

  • Neuroscience
  • Biochemistry

Background:

  • Parvalbumin is a calcium-binding protein found in specific neuronal populations.
  • Alterations in parvalbumin levels have been implicated in various neurological disorders.

Purpose of the Study:

  • To quantify parvalbumin concentrations in distinct cerebrocortical regions of Alzheimer's disease patients and age-matched controls.
  • To investigate regional differences in parvalbumin levels associated with Alzheimer's disease pathology.

Main Methods:

  • Sensitive enzyme immunoassay system used to measure parvalbumin.
  • Analysis conducted on four cerebrocortical regions: frontal lobe, temporal lobe (parahippocampal gyrus), parietal lobe, and occipital lobe.
  • Comparison between Alzheimer's disease patients and age-matched controls.

Related Experiment Videos

Main Results:

  • Parvalbumin concentrations were highest in the calcarine area and lowest in the parahippocampal gyrus in controls.
  • Alzheimer's disease patients showed significantly lower parvalbumin levels (less than half) in the parahippocampal gyrus compared to controls (P < 0.01).
  • No significant differences in parvalbumin concentrations were observed in the other three brain regions examined.

Conclusions:

  • Parvalbumin levels are selectively reduced in the parahippocampal gyrus in Alzheimer's disease.
  • This finding suggests a potential role for parvalbumin deficits in the temporal lobe pathology of Alzheimer's disease.
  • Further research is warranted to explore the functional implications of these regional parvalbumin changes.